drugset / Trial / NCT00575796

Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)

NCT00575796

NaSingle-groupOpen-labelTreatment

Summary

The overall objective of this study is to determine the efficacy of weekly Vinblastine in chemotherapy naïve patients with progressive or incompletely resected paediatric low grade glioma, to generate estimates of the response rate, progression-free survival, toxicity and quality of daily living among the population treated and determine biologic factors which will enable us to predict tumour behaviour.

Timeline

Start
2007-10
Primary completion
2018-10
Completion
2019-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Vinblastine Small molecule 6 mg/m2 Intravenous

Indications